KLP Kapitalforvaltning’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Hold
15,900
﹤0.01% 2039
2026
Q1
$108K Hold
15,900
﹤0.01% 2032
2025
Q4
$185K Buy
15,900
+900
+6% +$9.95K ﹤0.01% 1863
2025
Q3
$174K Buy
15,000
+3,300
+28% +$39.9K ﹤0.01% 1874
2025
Q2
$144K Hold
11,700
﹤0.01% 1903
2025
Q1
$72.1K Buy
+11,700
New +$121K ﹤0.01% 2125

Other funds holding CRMD

KLP Kapitalforvaltning's CRMD Position: Q2 2026 in Review

KLP Kapitalforvaltning held its CorMedix (CRMD) position steady in Q2 2026 at 15,900 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

KLP Kapitalforvaltning first reported a position in CRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $185K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • KLP Kapitalforvaltning held 15,900 shares of CorMedix worth $125K as of Q2 2026.
  • KLP Kapitalforvaltning left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2039 holding.
  • KLP Kapitalforvaltning first reported a position in CorMedix in Q1 2025 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's CorMedix position peaked at $185K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.